Mechanoreceptor-mediated modulation of nociceptive signaling via gate control theory

The "gate control theory of pain," introduced by Melzack and Wall (1965), proposes that the transmission of pain signals in the spinal cord can be modulated by concurrent activation of mechanoreceptor afferents (e.g., touch, pressure, vibration) and descending inputs from the brain. Mechanoreceptors, through large-diameter Aβ fibers, activate inhibitory interneurons in the dorsal horn of the spinal cord, which inhibit the relay (T) cells transmitting nociceptive signals from small-diameter pain fibers (Aδ and C fibers). When mechanoreceptors are active, they can "close the gate" to pain, reducing pain perception; when inactive, nociceptor input predominates and the "gate opens," increasing pain perception. This mechanism underlies clinical observations such as pain relief from rubbing injured tissue or therapies like transcutaneous electrical nerve stimulation (TENS). The gate control mechanism is a neural network-level process, not a single protein or gene, and thus is not a conventional therapeutic target from a molecular pharmacology perspective. This entry is not a canonical molecular target but a theoretical model for neural regulation of pain involving multiple neural types and synaptic mechanisms. There are no defined drug-target interactions, specific abbreviations, or molecular biomarkers corresponding to this term. The process does, however, underpin important principles in clinical pain management and the development of certain analgesic strategies.

Other names

Gate control of painGate control theory of pain modulationMechanoreceptor gating of nociception

Drugs that act on spinal interneurons, opioid receptors, or modulate activity of large-diameter (Aβ) mechanoreceptive fibers (e.g., neuromodulation, TENS) can indirectly influence the gate